Related Experiment Videos
Overall prognosis as the primary criterion of outcome in a clinical trial
Insights
This study aimed to determine the best intervention strategy for premature infants by assessing lifetime prognosis. Developing a comprehensive rating system for overall prognosis presented significant theoretical and practical challenges.
Area of Science:
- Neonatology
- Pediatric Medicine
- Clinical Trials
Background:
- Premature infants require interventions with long-term health implications.
- Assessing the lifetime prognosis of infants is crucial for evaluating treatment effectiveness.
- Interventions can impact multiple organ systems, necessitating a holistic approach to outcome assessment.
Purpose of the Study:
- To identify the optimal intervention strategy for premature infants based on lifetime prognosis.
- To develop and apply a method for assessing overall prognosis in a randomized trial.
- To compare different intervention strategies by evaluating their long-term impact on infant health.
Main Methods:
- A randomized trial was conducted with premature infants.
- Follow-up was performed up to one year of age.
- A novel scheme for rating overall lifetime prognosis was developed and applied.
Main Results:
- The study focused on the methodology for assessing lifetime prognosis rather than specific treatment outcomes.
- Significant theoretical and practical challenges were encountered in developing the overall prognosis rating scheme.
- The application of the rating scheme was a key component of the study.
Conclusions:
- Evaluating lifetime prognosis is essential for comparing interventions in premature infants.
- Developing a comprehensive prognosis assessment tool is complex but necessary for informed clinical decisions.
- This research highlights the challenges in predicting long-term outcomes for high-risk infant populations.
Abstract:
In a randomized trial on premature infants, with follow-up to 1 year of age only, the goal is to identify which one among the compared strategies of intervention affords the best outcome throughout life. This requires the assessment of lifetime prognosis at the end of follow-up as the primary criterion of outcome. Moreover, with the treatments potentially influencing a variety of organ systems, it is necessary to combine their separate prospects into an overall prognosis as a basis for identifying the preferable mode of intervention. The development of the scheme of rating overall prognosis posed considerable challenges, in theory as well as in application.